Immediate steps Contact your healthcare provider for evaluation and treatment
Safety of novel microbes for human consumption: practical examples of assessment in the European union
If the patient meets FDA labeling criteria for a GLP-1 agent (BMI 30, or BMI 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia), the clinician issues a prescription
Patients using oral contraceptives should specifically discuss the need for alternative or additional contraception for 4 weeks after starting Zepbound and for 4 weeks after each dose increase, due to delayed gastric emptying that may reduce oral contraceptive effectiveness
Theyve nicknamed the product natures Ozempic, a play on the popular type 2 diabetes drug that became a phenomenon when it was discovered to cause weight loss
This means that many supplement products reach the market without independent clinical scrutiny